Regeneron Pharmaceuticals... (REGN)

AI Score

Hold

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

731.30

0.08%

After-hours Dec 13, 2024, 04:15 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06	FY05	FY04	FY03	FY02	FY01	FY00	FY99	FY98	FY97	FY96	FY95	FY94	FY93	FY92	FY91	FY90
Revenue	13.12B	12.17B	16.07B	8.50B	7.86B	6.71B	5.87B	4.86B	4.10B	2.82B	2.10B	1.38B	445.82M	459.07M	379.27M	238.46M	125.02M	63.45M	66.19M	174.02M	57.50M	21.99M	21.97M	59.28M	34.50M	38.20M	33.10M	24.10M	27.40M	23.20M	10.60M	11.50M	7.30M	5.00M
Cost of Revenue	1.82B	1.56B	2.44B	1.12B	782.20M	434.10M	397.06M	299.69M	392.71M	205.02M	155.35M	84.45M	4.22M	2.09M	1.69M	923.00K	-	8.15M	9.56M	15.21M	6.68M	6.48M	6.51M	15.57M	3.60M	5.00M	2.60M	1.10M	-	-	-	-	12.80M	6.30M
Gross Profit	11.30B	10.61B	13.63B	7.38B	7.08B	6.28B	5.48B	4.56B	3.71B	2.61B	1.95B	1.29B	441.61M	456.98M	377.58M	237.53M	125.02M	55.30M	56.64M	158.80M	50.82M	15.51M	15.46M	43.71M	30.90M	33.20M	30.50M	23.00M	27.40M	23.20M	10.60M	11.50M	-5.50M	-1.30M
Operating Income	4.05B	4.74B	8.95B	3.58B	2.21B	2.53B	2.08B	1.33B	1.25B	838.43M	760.03M	457.71M	-205.16M	-97.47M	-74.10M	-89.83M	-114.45M	-107.66M	124.42M	5.65M	-99.99M	-121.95M	-85.68M	-25.28M	-23.80M	-12.60M	-7.50M	-17.30M	-7.60M	-29.20M	-38.80M	-18.30M	-9.60M	-3.30M
Interest Income	495.90M	160.10M	45.80M	18.50M	30.20M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pretax Income	4.20B	4.86B	9.33B	3.81B	2.43B	2.55B	2.08B	1.33B	1.23B	775.75M	713.36M	414.42M	-222.89M	-104.47M	-71.95M	-80.36M	-93.56M	-91.11M	124.42M	53.87M	-95.53M	-112.52M	-73.52M	-29.85M	-22.80M	-8.20M	-7.50M	-17.30M	-7.60M	-	-	-	-4.40M	-
Net Income	3.95B	4.34B	8.08B	3.51B	2.12B	2.44B	1.20B	895.52M	636.06M	348.07M	424.36M	750.27M	-221.76M	-104.47M	-67.83M	-82.71M	-105.60M	-102.34M	-95.45M	41.70M	-107.46M	-124.38M	-76.18M	-23.21M	-23.10M	-8.60M	-11.60M	-32.40M	-23.50M	-30.70M	-39.90M	-19.10M	-4.50M	-3.30M
Selling & General & Admin	2.63B	2.12B	1.82B	1.35B	1.83B	1.56B	1.32B	1.18B	838.53M	504.75M	329.42M	210.75M	117.26M	65.20M	52.92M	49.35M	37.87M	25.89M	25.48M	17.06M	14.79M	12.53M	9.61M	8.31M	6.40M	5.80M	5.80M	5.90M	5.80M	8.50M	46.30M	27.80M	3.30M	1.70M
Research & Development	4.44B	3.59B	2.91B	2.73B	3.04B	2.19B	2.08B	2.05B	1.62B	1.27B	859.95M	625.55M	529.51M	489.25M	398.76M	278.02M	201.61M	137.06M	155.58M	136.09M	136.02M	124.93M	91.54M	56.26M	44.90M	37.00M	27.80M	28.30M	23.30M	39.70M	-	-	-	-
Other Expenses	-	-89.90M	-45.60M	-280.40M	219.30M	19.10M	-1.08M	-926.00K	-	-	-	-	-	-	-	-	-	-	-248.84M	-	-	-	-	4.42M	3.40M	3.00M	4.40M	6.10M	5.90M	4.20M	3.10M	2.00M	800.00K	300.00K
Operating Expenses	7.25B	5.62B	4.69B	3.80B	4.87B	3.74B	3.40B	3.23B	2.46B	1.78B	1.19B	836.31M	646.77M	554.45M	451.69M	327.36M	239.48M	162.96M	-67.78M	153.16M	150.81M	137.46M	101.15M	68.99M	54.70M	45.80M	38.00M	40.30M	35.00M	52.40M	49.40M	29.80M	4.10M	2.00M
Interest Expense	73.00M	59.40M	57.30M	56.90M	30.20M	28.20M	25.12M	7.20M	14.24M	37.37M	46.44M	45.30M	21.28M	9.12M	2.34M	7.75M	12.04M	-	-	-	-	-	-	4.58M	-	-	3.40M	14.30M	14.70M	-	-	-	-	-
Selling & Marketing Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	9.07B	7.18B	7.12B	4.92B	5.65B	4.18B	3.79B	3.53B	2.85B	1.98B	1.34B	920.76M	650.98M	556.55M	453.37M	328.29M	239.48M	171.10M	-58.23M	168.37M	157.49M	143.94M	107.66M	84.55M	58.30M	50.80M	40.60M	41.40M	35.00M	52.40M	49.40M	29.80M	16.90M	8.30M
Income Tax	245.70M	520.40M	1.25B	297.20M	313.30M	109.10M	880.00M	434.29M	589.04M	427.67M	289.00M	-335.85M	-1.13M	-2.12M	-4.12M	2.35M	-29.75M	-21.87M	178.85M	-84.28M	3.01M	-7.01M	-21.66M	2.51M	-1.70M	-8.40M	7.50M	29.40M	30.60M	1.50M	1.10M	800.00K	-10.30M	-
Shares Outstanding (Basic)	106.70M	107.10M	105.70M	107.60M	109.20M	114.80M	115.90M	116.25M	115.23M	113.41M	111.22M	111.07M	90.61M	82.93M	79.78M	78.83M	66.33M	57.97M	55.95M	55.42M	50.45M	43.95M	42.09M	35.17M	31.22M	30.71M	29.00M	24.46M	19.75M	18.95M	16.56M	15.40M	15.52M	15.36M
Shares Outstanding (Diluted)	113.70M	113.50M	112.20M	115.10M	114.60M	114.80M	115.91M	116.30M	115.23M	113.47M	111.29M	115.38M	90.61M	82.93M	79.78M	78.83M	66.33M	57.97M	55.95M	56.17M	50.45M	43.95M	42.09M	35.17M	31.45M	31.00M	29.00M	24.46M	19.75M	18.95M	16.56M	15.40M	15.52M	15.36M
EPS (Basic)	37.05	40.51	76.40	32.65	19.38	21.29	11.27	8.55	6.17	3.36	4.23	7.92	-2.45	-1.26	-0.85	-1.05	-1.59	-1.77	-1.71	0.75	-2.13	-2.83	-1.81	-0.66	-0.74	-0.28	-0.4	-1.32	-1.19	-1.62	-2.41	-1.24	-0.29	-0.21
EPS (Diluted)	34.77	38.22	71.97	30.52	18.46	21.29	10.34	7.70	5.52	2.98	3.72	6.75	-2.45	-1.26	-0.85	-1.05	-1.59	-1.77	-1.71	0.74	-2.13	-2.83	-1.81	-0.66	-0.73	-0.28	-0.4	-1.32	-1.19	-1.62	-2.41	-1.24	-0.29	-0.21
EBITDA	4.69B	5.34B	9.28B	3.90B	2.42B	2.68B	2.08B	1.44B	1.33B	876.61M	784.25M	496.67M	-170.53M	-75.66M	-55.37M	-61.32M	-82.07M	-93.06M	139.93M	-27.22M	-91.51M	-113.50M	-79.61M	-20.86M	-20.40M	-9.50M	-9.30M	-11.20M	-1.70M	-25.00M	-35.70M	-16.30M	-8.80M	-3.00M
Depreciation & Amortization	421.00M	341.40M	286.20M	235.90M	210.30M	148.20M	145.47M	104.75M	74.91M	52.69M	41.20M	36.94M	31.08M	19.69M	14.25M	11.29M	11.49M	14.59M	15.50M	15.36M	12.94M	8.45M	6.08M	4.42M	3.40M	3.00M	4.40M	6.10M	5.90M	4.20M	3.10M	2.00M	800.00K	300.00K